JP2021530438A5 - - Google Patents

Info

Publication number
JP2021530438A5
JP2021530438A5 JP2020567123A JP2020567123A JP2021530438A5 JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5 JP 2020567123 A JP2020567123 A JP 2020567123A JP 2020567123 A JP2020567123 A JP 2020567123A JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5
Authority
JP
Japan
Prior art keywords
antibody
pharmaceutical composition
composition according
seq
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567123A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530438A (ja
JP7357646B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/034423 external-priority patent/WO2019232070A1/en
Publication of JP2021530438A publication Critical patent/JP2021530438A/ja
Publication of JP2021530438A5 publication Critical patent/JP2021530438A5/ja
Application granted granted Critical
Publication of JP7357646B2 publication Critical patent/JP7357646B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567123A 2018-05-29 2019-05-29 乾癬の治療のための組成物及び方法 Active JP7357646B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862677590P 2018-05-29 2018-05-29
US62/677,590 2018-05-29
PCT/US2019/034423 WO2019232070A1 (en) 2018-05-29 2019-05-29 Compositions and methods for treatment of psoriasis

Publications (3)

Publication Number Publication Date
JP2021530438A JP2021530438A (ja) 2021-11-11
JP2021530438A5 true JP2021530438A5 (enExample) 2022-06-06
JP7357646B2 JP7357646B2 (ja) 2023-10-06

Family

ID=68697289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567123A Active JP7357646B2 (ja) 2018-05-29 2019-05-29 乾癬の治療のための組成物及び方法

Country Status (9)

Country Link
US (1) US12016921B2 (enExample)
EP (1) EP3801590A4 (enExample)
JP (1) JP7357646B2 (enExample)
KR (1) KR102940600B1 (enExample)
CN (1) CN112689512B (enExample)
AU (1) AU2019279883B2 (enExample)
CA (1) CA3101767A1 (enExample)
IL (1) IL278978B2 (enExample)
WO (1) WO2019232070A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
WO2019232081A1 (en) * 2018-05-29 2019-12-05 Abcentra, Llc Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis
CA3160636A1 (en) * 2019-11-12 2021-05-20 Abcentra, Llc Methods and compositions for treating cancer
KR20250173600A (ko) 2023-03-17 2025-12-10 옥시토프 파마 비.브이. 항-포스포콜린 항체 및 그 사용 방법
WO2025151468A1 (en) * 2024-01-08 2025-07-17 Abcentra, Llc Methods of identifying a subject for treatment with antibodies against oxidized low density lipoprotein using pericoronary fat attenuation index

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
WO2008104194A1 (en) * 2007-02-28 2008-09-04 Bioinvent International Ab Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques
WO2009032702A2 (en) * 2007-08-28 2009-03-12 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
UA100255C2 (uk) * 2007-12-28 2012-12-10 Біоінвент Інтернешенл Аб Фармацевтична композиція
WO2009117289A2 (en) 2008-03-18 2009-09-24 Abbott Laboratories Methods for treating psoriasis
AU2010286532A1 (en) * 2009-08-28 2012-04-12 Bioinvent International Methods of treatment using anti-oxidized LDL antibodies
CN103813804A (zh) * 2010-10-06 2014-05-21 Abbvie公司 用于治疗银屑病的方法
WO2016024254A1 (en) * 2014-08-15 2016-02-18 Fundació Hospital Universitari Vall D’Hebron-Institut De Recerca Therapy selection for psoriasis and psoriatic arthritis
WO2019232081A1 (en) * 2018-05-29 2019-12-05 Abcentra, Llc Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis

Similar Documents

Publication Publication Date Title
JP2021530438A5 (enExample)
US20240417455A1 (en) Treatment for rheumatoid arthritis
AU2018200915B2 (en) Prevention of Adverse Effects Caused by CD3 Specific Binding Domains
JP2023515271A5 (enExample)
AU2017201201B2 (en) Treatment for dermatological pathologies
JP6554155B2 (ja) Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法
RU2016136364A (ru) Способы лечения или предупреждения астмы посредством введения антагониста il-4r
JP2024001125A (ja) Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2023520676A5 (enExample)
RU2019111921A (ru) Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r
JP2017511316A5 (enExample)
JP2024530954A5 (enExample)
JP2024516698A5 (enExample)
JP2024016237A5 (enExample)
JP2023545084A5 (enExample)
JP2021529766A5 (enExample)
CN109806393B (zh) 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途
JP2020521798A5 (enExample)
JP2024536106A5 (enExample)
JP2024522620A5 (enExample)
TW202206457A (zh) 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體
Mittal et al. Monica S. Tandon, Ankit Sharma
CA2884124C (en) Treatment for rheumatoid arthritis
RU2024105814A (ru) Лечение атопического дерматита
TH2101002581A (th) วิธีการทรีตโรคตาโปนจากไทรอยด์โดยใช้แอนติบอดีชนิด anti-fcrn